Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows. The new molecule combines the specificity of a mature flu fighter with the ...

Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.

Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.

The Global Virus Network, a group that represents virologists from more than 40 countries, has called on governments around ...

While current influenza vaccines primarily target the variable hemagglutinin protein, the slower-evolving neuraminidase presents a promising target for the development of new vaccines providing ...

The spread of H5N1 avian influenza virus in the United States has sparked fears of a potential pandemic. The H5N1 virus is ...

Global Virus Network warns of potential H5N1 pandemic, citing outbreaks in US dairy cows and humans. The virus, primarily ...

In the study, scientists describe a process they've developed for creating doses with precise amounts of two key proteins—hemagglutinin (H5) and neuraminidase (N1)—that prompt the body's immune system ...

Studies of treatment with neuraminidase inhibitors have not shown sufficient evidence that they prevent transmission to contacts. We conducted a multicountry, phase 3b trial to assess the efficacy ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Specific recognition of glycans by proteins is important in many biological processes ...